SYK EBITDA
$6.69BTTM · USD
Period ending:
SYK FY EBITDAUSD
$6.31B$0.00
1985-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
SYK ebitda history
Earnings before interest, taxes, depreciation, and amortization. The available annual fiscal periods series contains 41 observations from Dec 31, 1985 to Dec 31, 2025.
| Period ending | EBITDA (USD) |
|---|---|
| 6,314,000,000 | |
| 6,006,000,000 | |
| 5,057,000,000 | |
| 4,018,000,000 | |
| 3,608,000,000 | |
| 3,081,000,000 | |
| 3,627,000,000 | |
| 3,343,000,000 | |
| 2,952,000,000 | |
| 2,695,000,000 | |
| 2,240,000,000 | |
| 1,651,000,000 | |
| 1,614,000,000 | |
| 2,049,000,000 | |
| 2,261,000,000 | |
| 2,217,300,000 | |
| 2,023,700,000 | |
| 1,998,300,000 | |
| 1,758,900,000 | |
| 1,445,100,000 | |
| 1,252,200,000 | |
| 974,700,000 | |
| 901,000,000 | |
| 750,800,000 | |
| 644,600,000 | |
| 599,000,000 | |
| 527,500,000 | |
| 242,100,000 | |
| 233,500,000 | |
| 168,900,000 | |
| 186,000,000 | |
| 141,400,000 | |
| 108,100,000 | |
| 85,100,000 | |
| 63,300,000 | |
| 42,800,000 | |
| 38,000,000 | |
| 32,400,000 | |
| 26,200,000 | |
| 22,100,000 | |
| 17,600,000 |
Compare ebitda
Other companies in Healthcare. Each page shows its own reporting periods and currency.
- Lilly (Eli) (LLY) ebitda
- Johnson & Johnson (JNJ) ebitda
- AbbVie (ABBV) ebitda
- UnitedHealth Group (UNH) ebitda
- Merck & Co. (MRK) ebitda
- Thermo Fisher Scientific (TMO) ebitda
- Amgen (AMGN) ebitda
- Gilead Sciences (GILD) ebitda
All SYK financial metrics · SYK stock overview · How to interpret financial metrics
